Kidney Club Conference

Wednesday, December 11, 2024, 7:00 PM - 8:00 PM, Irvine, CA, Irvine, CA


AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

1 hour educational session presenting UCI faculty overview of late-breaking trials.

1. Analyze current guidelines and develop a strategy to apply in the overall care of patients with CKD, kidney transplants, hypertension, fluid, electrolyte and acid base disorders
2. Critically review and analyze the care of patients undergoing renal replacement therapy using national guidelines and best practices.
3. Critically analyze data from clinical research findings or updated care guidelines and apply it to the care of patients.

ADA Statement: In compliance with the Americans with Disabilities Act, we will make every reasonable effort to accommodate your request.  For any special requests, please contact the activity administrator before the meeting date.

The University of California, Irvine School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

University of California, Irvine School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Wednesday, December 11, 2024

We wish to thank Otsuka Pharmaceuticals for exhibiting at this session.